Randall A. Oyer

TL;DR: In this paper, the authors showed that CD8 T cell responses to vaccination might provide protection in patients with hematologic cancer even in the setting of limited humoral responses, including those treated with anti-CD20 therapy.

TL;DR: In this article, the authors found that patients with hematologic cancers had a significantly higher mortality relative to patients with solid cancers after accounting for confounders including ECOG performance status and active cancer status.

TL;DR: The recommendations are intended to serve as a guide for the research community to improve participation rates among people from racial and ethnic minority populations historically under-represented in cancer clinical trials.

TL;DR: The factors contributing to an increasingly strained oncology careforce are characterized, multilevel strategies to improve its efficiency, effectiveness, and resilience are presented, and these will enable today's oncologists careforce to provide high-quality care to more patients while simultaneously improving the patient, caregiver, and clinician experience.

TL;DR: This paper shares the experiences of four diverse groups participating in OCM, three practices and one network of practices, halfway through the model's projected 5-year lifecycle in the expectation that these experiences will be of value to other practices embarking toward patient-centered, high-value practice transformation.